SLC12A5 and prostate cancer: The oncogenic function for SLC12A5 has been reported in colorectal cancer, bladder urothelial carcinoma and prostate cancer that upregulation of SLC12A5 can promote tumour progression and increase cell invasion and metastasis ability in vivo and in vitro.7, 8, 9